Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of chemical constituents of Sabia parviflora by ultrahigh performance liquid chromatography quadrupole time of flight tandem mass spectrometry.

Journal of chromatography. A·2022
Same author

Global and national trends in years of life lost and years lived with disability caused by three common gastrointestinal cancers from 1990 to 2019.

BMC gastroenterology·2022
Same author

Photoaging mechanisms of microplastics mediated by dissolved organic matter in an iron-rich aquatic environment.

The Science of the total environment·2022
Same author

Occurrence and risk of iodinated X-ray contrast media in source and tap water from Jiangsu province, China.

Journal of hazardous materials·2022
Same author

Construction of a novel immune-related prognostic-predicting model of gastric cancer.

Gene·2022
Same author

Design and Structural Optimization of Orally Bioavailable SOS1 Inhibitors for the Treatment of KRAS-Driven Carcinoma.

Journal of medicinal chemistry·2022

Related Experiment Video

Updated: Jun 1, 2025

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

10.8K

Advances in the relationship between AP-1 and tumorigenesis, development and therapy resistance.

Xinni Xue1, Zhiwei Li1, Jiahui Zhao2

  • 1NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, 130021, Jilin, China.

Discover Oncology
|January 20, 2025
PubMed
Summary
This summary is machine-generated.

Activating protein 1 (AP-1) drives cancer development and resistance to therapy. AP-1 inhibitors show anti-cancer effects, but further research is needed to understand its complex mechanisms for targeted cancer treatments.

Keywords:
AP-1Drug resistanceRadiation resistanceTumorigenesisTumors

More Related Videos

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
05:21

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy

Published on: October 6, 2014

9.7K
In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

10.6K

Related Experiment Videos

Last Updated: Jun 1, 2025

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

10.8K
Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
05:21

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy

Published on: October 6, 2014

9.7K
In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

10.6K

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Activating protein 1 (AP-1) is a crucial transcription factor regulating cell proliferation, differentiation, apoptosis, and inflammation.
  • AP-1 activity is implicated as a driver in cancer onset, development, invasion, migration, and resistance to chemotherapy and radiation.

Purpose of the Study:

  • To elucidate the role of AP-1 in tumor progression and therapeutic resistance.
  • To review current AP-1 targeting drugs and their anti-cancer efficacy.
  • To explore the future therapeutic potential of targeting AP-1 in cancer treatment.

Main Methods:

  • Literature review of studies on AP-1 function in cancer.
  • Analysis of current research on AP-1 inhibitors and their clinical effects.
  • Synthesis of information on the complex mechanisms of AP-1 in different tumor types.

Main Results:

  • AP-1 plays a significant role in various cellular processes critical to cancer.
  • Existing AP-1 inhibitors demonstrate some anti-cancer activity.
  • The diverse roles of AP-1 structures necessitate further investigation into its precise mechanisms.

Conclusions:

  • AP-1 is a promising therapeutic target for cancer due to its involvement in tumor growth and resistance.
  • Development of AP-1-targeted therapies requires a deeper understanding of its complex functions.
  • Further research is essential to fully realize the therapeutic value of targeting AP-1 in oncology.